Circulating Periostin Levels do not Differ Between Postmenopausal Women with Normal and Low Bone Mass and are not Affected by Zoledronic Acid Treatment

  • P. Makras, M. Savvides, G. Sakellariou, A. Gkiomisi, A. Papatheodorou, E. Terpos, A. Anastasilakis, S. Polyzos
  • Hormone and Metabolic Research, August 2013, Thieme Publishing Group
  • DOI: 10.1055/s-0033-1351250

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Athanasios D Anastasilakis